Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Senate bill would cap Medicare drug costs at $7,500

Medicare enrollees would have out-of-pocket drug costs capped at $7,500 under a proposed Senate bill that would take effect in 2018.

House proposal would separate CISO, CIO roles within HHS

Change in the CIO-CISO reporting structure was the top recommendation of an August 2015 report by the House Energy and Commerce Committee.

Senate bill would increase healthcare options for veterans

Sen. John McCain, R.-Ariz.,, fed-up with the slow pace of improvements in the Department of Veterans Affairs’ system, proposed legislation that would allow veterans to go anywhere for healthcare.

CMS rolls out MACRA regulation

CMS announced plans to replace its current meaningful use program for physicians participating in the Medicare program.

U of Chicago Medicine’s expansion criticized by state regulators

A $269 million expansion to add a new cancer and trauma center at the University of Chicago Medical Center may be too costly and could outpace local need for more beds

MassHealth hopes to transition to ACO to control costs

A proposed overhaul of Massachusetts’ Medicaid program, MassHealth, would transition the program from fee-for-service to an accountable care organization (ACO) model by 2017 in an effort to keep costs down.

Two Illinois hospitals battle over disclosing insurer agreements

Advocate Health Care is suing Palos Community Hospital over a request for access to Advocate’s rate agreements with insurers, though Advocate had asked for and received the same information from the Palos hospital.

Thumbnail

CMS issues final rule on Medicaid managed-care plans

New standards include an 85 percent medical-loss ratio (MLR) requirement, along with changes to behavioral health coverage.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup